Skip to main content

Scientists to grow novel coronavirus in human cells for vitro testing

As per the CCMB scientists, the team will use Eyestem’s human lung epithelial cell culture system which will help in understanding the pathological and molecular characteristics of COVID-19.

Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has collaborated with Eyestem Research Private Limited, a Bengaluru based company for an attempt to grow novel coronavirus in human cells that will enable vitro testing of potential vaccines or drugs for the virus.
As per the CCMB scientists, the team will use Eyestem’s human lung epithelial cell culture system which will help in understanding the pathological and molecular characteristics of COVID-19.
CCMB is a laboratory of the Council of Scientific and Industrial Research (CSIR) which is known for its research work on cellular and molecular biology.
What can be expected from the study?
The test which will be performed in vitro means that it will be done outside the living organism which will involve isolated tissues, cells, or organs.
As per Dr. Rakesh Mishra, the Director of CCMB, to culture the virus in vitro (in the glass) outside the human host can prove to be quite challenging. He further stated that Eyestem’s cell culture system expresses the ACE2 receptor and other forms of genes that have been key determinants of replication and viral entry.
It has been hoped that employing this system will allow the CCMB team which is led by Dr. Krishnana Harshan in growing the virus predictably and also open up the potential of vaccine development and drug screening.
CEO of Eyestem, Dr. Jogin Desai stated that he hopes that CCMB will be able to use this platform in advancing the research of COVID-19. He further mentioned that the ACS platform has been developed by Dr. Rajarshi Pal and his team. The platform is a testament of Eyestem’s depth and expertise in disease modeling and cell therapy.
Findings can be beneficial:
The findings from the study can be extremely beneficial at a time when scientists all over the world are trying to develop a vaccine to combat COVID-19.
Some of the organisations have already started with human testing and have moved from animal or lab testing. Drug makers all over the world have also been working round the clock so that the vaccine can be developed in the minimum of time against the widespread virus.

Comments

Popular posts from this blog

GK Questions and Answers: Geographical Indications (GI) Tags in India

A geographical indication (GI) is a name or sign used on certain products like agriculture, machinery products, and sweets, etc. which relates to a specific geographical location or origin (e.g., region, or country or a town). We have published a set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India. This set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India is very important for exams like UPSC/PSC/SSC/CDS etc. 1. Which was the first Indian product to get the geographical indication tag? (a).Aranmula Kannadi (b).Darjeeling Tea (c).Katarni Rice (d).Madhubani Paintings Answer:- b Explanation:-  Darjeeling Tea was the first Indian product to get the geographical indication tag in 2004.  2. How many products got GI tags till now? (a) 361 (b) 729 (c) 624 (d) None of the above Answer:- a Explanation:-  Till date 361 products have been issued GI tag. The latest recipient of the GI ta...

What is sero-surveillance? How will it help in tracking COVID-19 infection?

Sero-surveillance: The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The advisory further states that these tests can be carried out on frontline workers, medical professionals, vendors, police personnel, the staff of restaurants and grocery shops, etc. In addition to these, individuals residing in the containment zones and patients with chronic illness tuberculosis, HIV, etc. will also be covered.  The survey will also be conducted on asymptomatic individuals and the previously infected COVID-19 hit patients that have now recovered. The survey will be conducted with the help of the ELISA test kit.  What is sero-surveillance? In serosurvey or sero-surveillance, testing of blood serum of a group of individuals is c...

List of Top investors in Reliance Jio

Reliance Jio the digital platform has sold around 25% stake to different investors to get rid of the debt of the company by March 2021. Facebook is the biggest investor that has purchased a 10% stake in the Jio Platform. The Reliance Industries Limited (RIL) was established by Ambani’s father, Dhirubhai Ambani in Maharashtra on 8 May 1973. Now Mukesh Ambani is the chairman and managing director of Reliance Industries Limited.  Mukesh is Asia’s richest and world 7th richest man. The RIL has sold 25% of the Jio Platforms stake to become a debt-free company by March 2021. At a time the company had a debt of Rs. 2.17 lakh crore but now it is having a debt of Rs. 21,900 crore. It is expected that the Jio might sell its stake to more companies like Google and other global giants. As of now the Reliance Jio the telecom and digital arm of RIL has raised $15.2 billion in 13 deals over two months. The Analysts predict the Jio could debut at a valuation of $100 billion within ...